-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) Reports In-Line Q1 EPS, provides guidance
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) PT Raised to $125 at H.C. Wainwright
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Update
-
-
-
-
-
-
-
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)
-
-
-
-
-
-
-
Rhythm Pharmaceuticals (RYTM) Reports In-Line Q4 EPS, provides guidance
-
-
-
-
-
-
-
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Update
-
1,233,847 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


